Yusuf, S., Ostergren, J. B., Gerstein, H., Pfeffer, M. A., Swedberg, K., Granger, C. B., & McMurray, J. J. V. (2004). 810-1 Impact of the angiotensin-receptor blocker candesartan in preventing diabetes in patients with heart failure. In Journal of the American College of Cardiology (Vol. 43, pp. A473–A473). Elsevier BV. https://doi.org/10.1016/s0735-1097(04)92003-7

Yusuf, Salim, Jan B. Ostergren, Hertzel Gerstein, Marc A. Pfeffer, Karl Swedberg, Chris B. Granger, and John J. V. McMurray. “810-1 Impact of the angiotensin-receptor blocker candesartan in preventing diabetes in patients with heart failure.” In Journal of the American College of Cardiology, 43:A473–A473. Elsevier BV, 2004. https://doi.org/10.1016/s0735-1097(04)92003-7.

Yusuf S, Ostergren JB, Gerstein H, Pfeffer MA, Swedberg K, Granger CB, et al. 810-1 Impact of the angiotensin-receptor blocker candesartan in preventing diabetes in patients with heart failure. In: Journal of the American College of Cardiology. Elsevier BV; 2004. p. A473–A473.

Yusuf, Salim, et al. “810-1 Impact of the angiotensin-receptor blocker candesartan in preventing diabetes in patients with heart failure.” Journal of the American College of Cardiology, vol. 43, no. 5, Elsevier BV, 2004, pp. A473–A473. Crossref, doi:10.1016/s0735-1097(04)92003-7.

Yusuf S, Ostergren JB, Gerstein H, Pfeffer MA, Swedberg K, Granger CB, McMurray JJV. 810-1 Impact of the angiotensin-receptor blocker candesartan in preventing diabetes in patients with heart failure. Journal of the American College of Cardiology. Elsevier BV; 2004. p. A473–A473.